| 摘要 |
The present invention relates to compounds of Formula (I), wherein: Ar, Arl, R3-R 5, E, F, T, Q and m are as defined in the specification. The compounds are useful as CCR-3 Receptor antagonists, and therefore, may be used for the treatment of CCR-3 mediated diseases.
|
